Paris: Havas today announced a strategic investment in and partnership with Ostro, a pioneering AI-powered engagement platform designed specifically for the life sciences industry. In an increasingly crowded digital healthcare landscape, Ostro cuts through the noise by delivering personalized healthcare journeys that connect life science companies with healthcare providers (HCPs) and patients—ultimately improving outcomes and increasing brand ROI.
This milestone aligns with Havas’ ongoing transformation strategy, reinforcing its leadership in data, technology, AI, and personalized content delivery. Ostro’s award-winning platform, already trusted by a majority of the top 10 global biopharma companies, is gaining traction across mid-sized pharma and emerging biotech due to its dynamic, compliant, and rapidly deployable digital engagement capabilities—branded or unbranded—in just eight weeks or less.
“At Havas, we constantly seek technologies that deliver meaningful value to our clients,” said Yannick Bolloré, Chairman and CEO of Havas. “Ostro is a transformative step forward in intelligent brand engagement and aligns perfectly with our Converged strategy and our €400 million investment in data, tech, and AI.”
The preferred partnership gives Havas exclusive access to Ostro’s technology across its global ecosystem—beginning with Havas Health Network clients and expanding across Havas Creative and Media Networks. The collaboration enhances omnichannel activations, modular content delivery, and smarter content workflows, supporting greater precision and personalization at scale.
“This partnership reflects our commitment to creativity and innovation in health and wellness,” said Donna Murphy, Global CEO, Havas Health & Creative Networks. “By blending creativity with AI-powered intelligence, we empower clients to deliver highly relevant, compliant, and personalized experiences.”
Advised by Houlihan Lokey, this investment underscores Havas’ broader strategy to accelerate innovation and digital transformation across the healthcare space.
“Ostro was built to make healthcare engagement intuitive and deeply personalized,” said Dr. Chase Feiger, CEO and Co-Founder of Ostro. “With Havas as our partner, we gain a global platform to amplify that mission.”
“Our platform is not static. It’s context-enabled, dynamic, and intelligent,” added Ahmed Elsayyad, President and Co-Founder of Ostro. “Together with Havas, we’re scaling agentic engagement to make every touchpoint smarter and more aligned across the healthcare journey.”
The partnership marks a bold new chapter in life sciences marketing—where AI meets creativity to shape a more adaptive, connected, and impactful brand experience.
